Shun Lu Selected Research

Phosphatidylinositol-4-Phosphate 3-Kinase

1/2018

Xenograft tumors derived from malignant pleural effusion of the patients with non-small-cell lung cancer as models to explore drug resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shun Lu Research Topics

Disease

124	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 02/2007
90	Neoplasms (Cancer) 10/2022 - 11/2008
62	Lung Neoplasms (Lung Cancer) 03/2022 - 12/2003
23	Disease Progression 10/2022 - 08/2011
22	Neoplasm Metastasis (Metastasis) 02/2022 - 09/2008
21	Adenocarcinoma of Lung 01/2022 - 09/2008
13	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 08/2015
11	Exanthema (Rash) 11/2022 - 08/2011
10	Carcinogenesis 04/2022 - 10/2013
8	Diarrhea 01/2022 - 01/2017
7	Carcinoma (Carcinomatosis) 10/2021 - 11/2018
6	Stomatitis 12/2022 - 02/2014
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2022 - 01/2015
6	Brain Neoplasms (Brain Tumor) 01/2022 - 11/2015
6	Neutropenia 01/2021 - 08/2011
6	Acne Vulgaris 01/2018 - 02/2014
6	Thrombocytopenia (Thrombopenia) 01/2018 - 09/2008
5	Adenocarcinoma 01/2022 - 11/2008
4	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 11/2013
4	Leukopenia 01/2021 - 07/2010
3	Pain (Aches) 12/2022 - 01/2015
3	Dyspnea (Shortness of Breath) 03/2022 - 01/2018
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2020
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 05/2020
3	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2021 - 05/2012
3	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2019
3	Vomiting 01/2020 - 02/2014
3	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 01/2015
3	Infections 01/2017 - 01/2010
2	Anemia 11/2022 - 10/2018
2	Cough 11/2022 - 01/2018
2	Hypertriglyceridemia 11/2022 - 11/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2018
2	Pleural Effusion (Pleural Effusions) 01/2021 - 01/2021
2	Paronychia 01/2021 - 02/2015

Drug/Important Bio-Agent (IBA)

38	ErbB Receptors (EGF Receptor)IBA 11/2022 - 04/2009
23	Tyrosine Kinase InhibitorsIBA 11/2022 - 08/2011
20	PlatinumIBA 05/2022 - 06/2009
19	Biomarkers (Surrogate Marker)IBA 02/2022 - 04/2009
18	AfatinibIBA 01/2022 - 02/2014
17	Immune Checkpoint InhibitorsIBA 05/2022 - 01/2019
14	Gefitinib (Iressa)FDA Link 01/2022 - 08/2011
13	Pharmaceutical PreparationsIBA 02/2022 - 06/2012
13	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2021 - 08/2011
12	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 02/2014
11	CrizotinibIBA 05/2022 - 01/2016
11	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2013
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2013
9	Anaplastic Lymphoma KinaseIBA 05/2022 - 05/2015
9	NivolumabIBA 04/2022 - 01/2019
9	Pemetrexed (MTA)FDA Link 01/2020 - 10/2009
9	Gemcitabine FDA Link 01/2019 - 08/2011
8	osimertinibIBA 02/2022 - 01/2018
8	Docetaxel (Taxotere)FDA Link 12/2021 - 06/2009
7	Biological ProductsIBA 10/2022 - 11/2010
6	B7-H1 AntigenIBA 02/2022 - 01/2019
5	Alanine Transaminase (SGPT)IBA 11/2022 - 08/2011
5	Phosphotransferases (Kinase)IBA 02/2022 - 05/2015
5	Small Interfering RNA (siRNA)IBA 09/2021 - 01/2013
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 04/2009
5	Carboplatin (JM8)FDA LinkGeneric 12/2019 - 08/2011
4	LigandsIBA 03/2022 - 01/2013
4	Circulating Tumor DNAIBA 01/2022 - 01/2019
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2006
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2019 - 09/2008
4	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 09/2019 - 01/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 03/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2013
3	pyrotinibIBA 01/2022 - 09/2021
3	aumolertinibIBA 01/2022 - 06/2021
3	EnzymesIBA 11/2021 - 05/2011
3	AntibodiesIBA 09/2021 - 12/2019
3	Messenger RNA (mRNA)IBA 09/2021 - 10/2013
3	HMPL-013IBA 02/2021 - 01/2018
3	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2017
3	Bevacizumab (Avastin)FDA Link 01/2021 - 07/2015
3	Protein Isoforms (Isoforms)IBA 12/2019 - 12/2013
3	Etoposide (VP 16)FDA LinkGeneric 12/2016 - 01/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2022 - 01/2021
2	brigatinibIBA 05/2022 - 11/2021
2	ceritinibIBA 05/2022 - 04/2017
2	alectinibIBA 05/2022 - 11/2021
2	IpilimumabIBA 04/2022 - 01/2021
2	Blood Proteins (Serum Proteins)IBA 03/2022 - 01/2017
2	InterferonsIBA 03/2022 - 01/2014
2	tislelizumabIBA 03/2022 - 05/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Circular RNAIBA 01/2022 - 01/2020
2	Peptides (Polypeptides)IBA 01/2022 - 06/2012
2	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 10/2021 - 01/2019
2	dacomitinibIBA 01/2021 - 01/2021

Therapy/Procedure

53	Therapeutics 10/2022 - 12/2003
53	Drug Therapy (Chemotherapy) 05/2022 - 02/2007
17	Immunotherapy 01/2022 - 06/2018
8	Radiotherapy 01/2022 - 11/2012
4	Adjuvant Chemotherapy 01/2022 - 06/2009
4	Precision Medicine 01/2020 - 01/2017
3	Pneumonectomy (Lung Volume Reduction) 01/2017 - 06/2009
2	Chemoradiotherapy 12/2022 - 12/2016
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 04/2022 - 10/2019